Was ist eine ansteckende Flechtenkrankheit?

Contagious impetigo, a bacterial skin infection primarily caused by *Staphylococcus aureus* or *Streptococcus pyogenes*, represents a dermatological condition affecting both pediatric and geriatric populations. Transmission may occur through primary infection—where bacteria penetrate minor epidermal abrasions—or secondarily via direct exposure to infected individuals or fomites such as towels, clothing, or toys. The clinical course is typically benign and self-limiting, resolving within 7–14 days. However, the absence of targeted therapy can prolong symptomatic persistence for 4–6 weeks and predispose patients to severe complications. The most critical sequelae of untreated impetigo include systemic sepsis, scarlet fever, postinfectious glomerulonephritis, and vasculitis within the urinary tract. Additionally, a subset of patients may develop permanent scarring, particularly in cases involving deep ulcerations or secondary infections.

Impetigo, classified as a bacterial skin infection of contagious nature, arises predominantly from cutaneous colonization by two key pathogenic agents: *Streptococcus pyogenes* (commonly misattributed to Group B in the original text but correctly identified as Group A streptococci) and *Staphylococcus aureus*. Of particular clinical significance is the potential for concurrent infection by both microorganisms, giving rise to mixed-form presentations with complex disease trajectories. The condition exhibits a marked predilection for specific anatomical regions, most notably the facial area—particularly the perioral and nasal zones—as well as the neck and the periungual folds of the hands. A defining feature is its multifocal propensity: exudative, erythematous, or vesicular lesions frequently emerge synchronously across multiple discrete body sites. A constellation of predisposing factors has been identified, categorizable into epidemiological, behavioral, environmental, and health-status-related domains. The most salient include: (1) *sociodemographic conditions*—elevated risk within high-density populations (e.g., daycare centers, military barracks, homeless shelters); (2) *physical activity*—contact sports such as wrestling, rugby, or football, where direct skin-to-skin exposure to infected individuals occurs; (3) *climatic variables*—high ambient temperatures coupled with humidity create optimal conditions for bacterial proliferation; (4) *skin barrier disruption*—even microscopic wounds (from insect bites, invasive procedures, or mechanical trauma) serve as portals of entry for pathogens; (5) *immunosuppression*—both iatrogenic (corticosteroid therapy, chemotherapy) and disease-associated (autoimmune disorders); (6) *suboptimal hygiene practices*—neglect of cleansing, disinfection, or skin protection; (7) *comorbidities*—including recurrent streptococcal pharyngitis, metabolic decompensation in diabetes mellitus, organ failure (renal, thyroid), chronic pharyngitis, and primary/secondary immunodeficiencies; (8) *nutritional disorders*—encompassing primary deficiencies (vitamin A, C, E, and zinc malabsorption) and secondary malnourishment stemming from substance dependencies (alcoholism), eating disorders (anorexia nervosa, bulimia), or gastrointestinal malignancies, all of which contribute to systemic immune compromise.

The primary and most recognizable symptom arising from staphylococcal or streptococcal infection—commonly referred to as impetigo—is the emergence of multiple small cutaneous vesicles filled with clear, serous exudate. The accompanying persistent pruritus, which leads to uncontrollable scratching, facilitates mechanical autoinoculation of the pathogen onto previously unaffected skin areas, thereby accelerating the dissemination of the infection. As the condition progresses, these vesicular lesions rupture, and their contents desiccate, forming distinctive thick, painful crusts ranging in color from golden yellow to honey-colored. It is essential to emphasize that infectious impetigo may present in three fundamental clinical forms, differing in lesion location, depth of tissue involvement, and associated systemic manifestations. The most prevalent variant is bullous impetigo, which does not induce regional lymphadenopathy and remains confined to superficial cutaneous changes. In contrast, the deeper form, known as ecthyma, is characterized by the development of deeply seated ulcerations that may be accompanied by systemic symptoms such as pyrexia. The third form, staphylococcal folliculitis, results in purulent inflammation within hair follicles, frequently affecting extensive skin regions and necessitating a more aggressive therapeutic approach.

Contagious impetigo represents a condition typically characterized by a brief and mild course, with effective management relying heavily on rigorous adherence to dermatological hygiene protocols, particularly in regions affected by inflammatory processes. Nevertheless, the cornerstone of treatment remains pharmacological intervention, primarily through topical antibiotic formulations such as ointments or sprays containing active agents like bacitracin, fusidic acid, or mupirocin, which are applied directly to the lesions. In instances where skin involvement is extensive, systemic oral antibiotic therapy may become necessary to achieve resolution.